BUY
₹108
₹106
₹143
32.41%
In its August 11, 2026 Q1FY27 result update, Prabhudas Lilladher retained its BUY recommendation on Lemon Tree Hotels and raised its target price to Rs 143 from Rs 138, compared with a CMP of Rs 108. The broker identifies margin recovery as the key potential re-rating driver.
Prabhudas Lilladher expects renovation intensity to taper to 1.9 per cent in FY27E and 1.3 per cent in FY28E. Pricing actions are expected to partly mitigate GST-related pressure, supporting EBITDA margin recovery to 48.6 per cent in FY27E and 49.8 per cent in FY28E, from 47.8 per cent in FY26.
Lemon Tree Hotels reported Q1FY27 net sales of Rs 3,446 million, up 9.1 per cent year-on-year and 3.9 per cent above the broker estimate of Rs 3,318 million. ARR rose 2.0 per cent year-on-year to Rs 6,361, while RevPAR increased 6.4 per cent to Rs 4,814. Occupancy stood at 75.7 per cent.
| Q1FY27 metric | Reported | Year-on-year change | Broker estimate |
|---|---|---|---|
| Net sales | Rs 3,446 million | Up 9.1% | Rs 3,318 million |
| ARR | Rs 6,361 | Up 2.0% | Not provided |
| RevPAR | Rs 4,814 | Up 6.4% | Not provided |
| Occupancy | 75.7% | Not provided | Not provided |
| EBITDA | Rs 1,497 million | Up 6.5% | Rs 1,456 million |
| EBITDA margin | 43.4% | Down 110 bps | 43.9% |
| Adjusted PAT after minority interest | Rs 460 million | Up 20.1% | Rs 377 million |
EBITDA was 2.8 per cent above Prabhudas Lilladher's estimate, although the EBITDA margin declined 110 basis points year-on-year to 43.4 per cent, slightly below the 43.9 per cent estimate. The margin decline reflected GST-related input-credit loss, estimated by the broker at around a 2.3 per cent impact, stock appreciation rights provisions, elevated renovation spending and continued technology investment.
Adjusted PAT after minority interest was materially above estimate because minority interest was lower than expected at Rs 113 million versus the Rs 203 million estimate.
Management is targeting an EBITDA margin of around 50 per cent by FY28E, with improvement expected from Q2FY27E as renovation costs taper and GST headwinds are partly offset. The asset-light management-fee business has a longer-term EBITDA-margin target of around 75-80 per cent.
The development pipeline includes Aurika Shimla with 90 rooms, Aurika Shillong with 165 rooms, Aurika Varanasi with 47 rooms and Aurika Delhi with around 572 rooms, subject to final approvals.
Prabhudas Lilladher expects a 9 per cent revenue CAGR over FY26-FY28E, driven by the Aurika Shillong and Aurika Shimla additions as well as renovation-led repricing.
| Financial year | Sales | EBITDA | Adjusted PAT |
|---|---|---|---|
| FY27E | Rs 15,570 million | Rs 7,570 million | Rs 2,828 million |
| FY28E | Rs 17,073 million | Rs 8,498 million | Rs 3,622 million |
Following the result, the broker raised its FY27E and FY28E sales estimates by 0.8 per cent and 1.5 per cent, respectively. EBITDA estimates were increased by 0.8 per cent and 2.0 per cent, while EPS estimates were raised by 2.9 per cent and 4.5 per cent, respectively.
The Rs 143 target price is based on a FY28E sum-of-the-parts valuation. Prabhudas Lilladher applies 22 times FY28E EBITDA to the fee business and 20 times to the asset-heavy business, with no change in target multiples.
| Valuation component | Value |
|---|---|
| Total enterprise value | Rs 1,19,581 million |
| Less: Debt | Rs 7,494 million |
| Add: Cash | Rs 1,142 million |
| Equity value | Rs 1,13,229 million |
| Shares considered | 792 million |
A possible catalyst is Fleur's expected demerger and listing in the first half of calendar year 2027, alongside a Rs 9,600 million Warburg Pincus fund infusion and more than 2,500 rooms under active discussion.
Key factors to monitor include the pace of renovation-cost reduction, the effectiveness of pricing actions in offsetting the GST impact, execution of new-room additions and final approval for Aurika Delhi.
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
Copyright 2026 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)